SKAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.521200E-01
Normal-vs-Stage2
8.627400E-01
Normal-vs-Stage3
2.049800E-01
Normal-vs-Stage4
3.027800E-01
Stage1-vs-Stage2
5.768000E-01
Stage1-vs-Stage3
2.601000E-01
Stage1-vs-Stage4
1.636240E-01
Stage2-vs-Stage3
8.728300E-02
Stage2-vs-Stage4
1.761650E-01
Stage3-vs-Stage4
1.783900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.724000E-01
Normal-vs-AfricanAmerican
9.697400E-01
Normal-vs-Asian
5.540800E-01
Caucasian-vs-AfricanAmerican
9.173600E-01
Caucasian-vs-Asian
2.225000E-01
AfricanAmerican-vs-Asian
4.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.404400E-01
Normal-vs-Female
8.812200E-01
Male-vs-Female
1.732620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.846000E-01
Normal-vs-Age(41-60Yrs)
7.241000E-01
Normal-vs-Age(61-80Yrs)
9.373400E-01
Normal-vs-Age(81-100Yrs)
9.002000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.508400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.172800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.122400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.278030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.823000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.592600E-01
Normal-vs-Daily Drinker
9.328600E-01
Normal-vs-Weekly Drinker
8.192600E-01
Normal-vs-Occasional Drinker
5.645600E-01
Normal-vs-Social Drinker
8.920200E-01
Non Drinker-vs-Daily Drinker
6.944200E-01
Non Drinker-vs-Weekly Drinker
9.431400E-01
Non Drinker-vs-Occasional Drinker
5.640300E-02
Non Drinker-vs-Social Drinker
7.385400E-01
Daily Drinker-vs-Weekly Drinker
7.447200E-01
Daily Drinker-vs-Occasional Drinker
1.923010E-01
Daily Drinker-vs-Social Drinker
9.593600E-01
Weekly Drinker-vs-Occasional Drinker
1.771400E-01
Weekly Drinker-vs-Social Drinker
7.774400E-01
Occasional Drinker-vs-Social Drinker
1.787580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.381800E-01
Normal-vs-Grade 2
4.858300E-02
Normal-vs-Grade 3
4.701800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.600110E-02
Grade 1-vs-Grade 3
1.128250E-02
Grade 1-vs-Grade 4
3.381800E-01
Grade 2-vs-Grade 3
4.229200E-01
Grade 2-vs-Grade 4
4.858300E-02
Grade 3-vs-Grade 4
4.701800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.808400E-01
Normal-vs-NonDiabetic
9.840800E-01
Diabetic-vs-NonDiabetic
8.870400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.603800E-01
Normal-vs-NoPancreatitis
9.921800E-01
Pancreatitis-vs-NoPancreatitis
9.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.882600E-01
Normal-vs-N1
8.292800E-01
N0-vs-N1
1.048190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.173000E-01
Normal-vs-TP53-NonMutant
6.693000E-01
TP53-Mutant-vs-TP53-NonMutant
4.761600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
